Impladent Ltd.

Impladent Ltd. develops and markets a broad range of innovative and affordable regenerative materials, including bone graft products and resorbable membranes. For over 30 years, Impladent Ltd. has been recognized as a leader in the innovation and development of synthetic resorbable bone grafts. In 1985, Impladent Ltd. introduced OsteoGen Synthetic Bioactive Resorbable Graft (SBRG) used for bone augmentation and repair of alveolar defects. OsteoGen Non-Ceramic Crystals are physiochemically and crystallographically equivalent to human trabecular bone making this product a pure alloplast.